These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15885576)

  • 61. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
    Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate.
    Long JP; Fallick ML; Rand W
    J Urol; 1997 May; 157(5):1723-6. PubMed ID: 9112513
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [PSA change and morbidity of prostate cancer after dietary intervention of low-fat and high-soybean-protein diet for patients with high serum PSA level].
    Tsutsumi M; Ishikawa S; Ishikawa Y
    Hinyokika Kiyo; 2004 Dec; 50(12):847-51. PubMed ID: 15682855
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.
    Han KR; Cohen JK; Miller RJ; Pantuck AJ; Freitas DG; Cuevas CA; Kim HL; Lugg J; Childs SJ; Shuman B; Jayson MA; Shore ND; Moore Y; Zisman A; Lee JY; Ugarte R; Mynderse LA; Wilson TM; Sweat SD; Zincke H; Belldegrun AS
    J Urol; 2003 Oct; 170(4 Pt 1):1126-30. PubMed ID: 14501706
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prostate cancer: gadolinium-enhanced MR imaging at 3 weeks compared with needle biopsy at 6 months after cryoablation.
    Donnelly SE; Donnelly BJ; Saliken JC; Raber EL; Vellet AD
    Radiology; 2004 Sep; 232(3):830-3. PubMed ID: 15273337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cryosurgical ablation for prostate cancer: preliminary results of a new advanced technique.
    Leibovici D; Zisman A; Siegel YI; Lindner A
    Isr Med Assoc J; 2001 Jul; 3(7):484-7. PubMed ID: 11791412
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does ischemia-induced prostate damage during cardiac surgery involving cardiopulmonary bypass cause bladder outlet obstruction?
    Guvel S; Turkoz R; Egilmez T; Kilinc F; Yaycioglu O; Atalay H; Ozkardes H
    Urol Int; 2005; 74(4):337-40. PubMed ID: 15897700
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective trial of cryosurgical ablation of the prostate: five-year results.
    Donnelly BJ; Saliken JC; Ernst DS; Ali-Ridha N; Brasher PM; Robinson JW; Rewcastle JC
    Urology; 2002 Oct; 60(4):645-9. PubMed ID: 12385926
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response.
    Connolly JA; Shinohara K; Presti JC; Carroll PR
    Urol Clin North Am; 1997 May; 24(2):415-20. PubMed ID: 9126239
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma.
    Long JP; Fallick ML; LaRock DR; Rand W
    J Urol; 1998 Feb; 159(2):477-84. PubMed ID: 9649266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined cryoablation and GM-CSF treatment for metastatic hormone refractory prostate cancer.
    Si T; Guo Z; Hao X
    J Immunother; 2009 Jan; 32(1):86-91. PubMed ID: 19307997
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Humoral immunity following double freezing of the prostate of patients with prostatic cancer.
    Ueda K; Ohtaguro K; Washida H; Jinno H; Fushimi N; Masegi T
    Prog Clin Biol Res; 1982; 107():815-26. PubMed ID: 7167530
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Changes in immunoparameters following cryosurgery in prostate cancer].
    Fukagai T; Tazawa K; Higaki Y; Imamura K
    Hinyokika Kiyo; 1990 Mar; 36(3):307-17. PubMed ID: 2353604
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Cryosurgery of the prostate gland].
    Freĭdovich AE
    Urol Nefrol (Mosk); 1970; 35(3):28-32. PubMed ID: 5448445
    [No Abstract]   [Full Text] [Related]  

  • 78. [Cryosurgery of the prostate].
    Reuter HJ
    Acta Urol Belg; 1970 Jan; 38(1):36-42. PubMed ID: 4104690
    [No Abstract]   [Full Text] [Related]  

  • 79. Cryosurgery of the prostate revisited.
    Chodak GW
    Cancer; 1993 Aug; 72(4):1145-6. PubMed ID: 7687920
    [No Abstract]   [Full Text] [Related]  

  • 80. Freezing the prostate.
    Matzkin H
    Isr Med Assoc J; 2001 Jul; 3(7):535. PubMed ID: 11791424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.